Susan Marlin is the President and CEO of Clinical Trials Ontario (CTO), an organization established by the Province of Ontario to make Ontario a preferred location for clinical trials while maintaining the highest ethical standards. Prior to joining CTO she served as the Associate Vice-Principal at Queen’s University. Susan worked with the National Cancer Institute of Canada Clinical Trials Group for many years, coordinating cancer clinical trials and leading the development of the Ethics and Regulatory Office.
Susan served as President of the Canadian Association of Research Ethics Boards, and as a member of the Canadian Institutes of Health Research (CIHR) Research Integrity Committee, the Ontario Cancer Research Ethics Board, the Tri-Agency Panel on the Responsible Conduct of Research, and the Ontario Government Life Sciences Working Group. She is currently a member of the Life Sciences Ontario Board of Directors and the Management Team for the Ontario SPOR (Strategy for Patient Oriented Research) Support Unit.
Susan was born and raised in Halifax, Nova Scotia. She holds a BSc (Hons) from Dalhousie University, and an MSc in Community Health and Epidemiology from Queen’s University. She was awarded the Queen’s Elizabeth II Diamond Jubilee medal in 2012 in recognition of her work in support of military and veteran health research.